Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations

Lung cancer is a malignant tumor with high incidence and mortality across the world. The use of immune checkpoint inhibitors for lung cancer has improved the prognosis of some lung cancer patients to a greater extent and provided a new direction for the clinical treatment of lung cancer. Immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yudie, Zhang, Xia, Gao, Yajie, Dong, Yan, Wang, Di, Huang, Yanping, Qu, Tianhao, Fan, Buqun, Li, Qizheng, Zhang, Chunxia, Cui, Xiaonan, Zhang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110674/
https://www.ncbi.nlm.nih.gov/pubmed/35236543
http://dx.doi.org/10.3727/096504022X16462176651719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110674/
https://www.ncbi.nlm.nih.gov/pubmed/35236543
http://dx.doi.org/10.3727/096504022X16462176651719

Ejemplares similares